Melanoma Research Alliance Foundation logo

Melanoma Research Alliance Foundation

WASHINGTON, DC EIN: 26-1636099 Website

The Melanoma Research Alliance (MRA) is the world's largest private nonprofit funder of melanoma research. Founded in 2007, the organization is based in Washington, DC and operates as a 501(c)(3) public charity. MRA funds scientific research aimed at preventing, detecting, and treating melanoma while supporting patients and families affected by the disease.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$25.2M

+2.7% YoY

Annual Giving

$11.9M

+93.1% YoY

Grant Count

29

+11.5% YoY

Avg Grant Size

$411K

+73.1% YoY

Research compiled by Grantable AI from public sources. Last updated April 2026.

Mission & Focus Areas

Mission: To end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas.

Primary Focus Areas:

  • Melanoma research funding through peer-reviewed grant programs
  • Prevention and sun safety education
  • Early detection and screening awareness
  • Patient and family support resources
  • Scientific agenda development through convening world-class, cross-disciplinary experts

MRA's research support encompasses investigations into causes, cures, prevention, early detection, treatment, metastasis, and survivorship related to melanoma.

Grantmaking

MRA has directly invested over $175 million toward scientific discoveries and research grants since inception. The organization supports research at domestic and foreign universities, medical schools, and nonprofit medical research organizations.

Ready to take the next step with Melanoma Research Alliance Foundation?

Geographic Focus

Where this funder awards grants

MRA funds melanoma research worldwide, supporting both domestic and international research institutions.

Grant Distribution by State

25states
+17 more states

Cities

AlbanyAlexandriaAnn ArborAtlantaAuroraBaltimoreBostonCambridgeCamdenChapel HillCharlestonCharlottesvilleChicagoClevelandDetroitDurhamEvanstonHersheyHoustonIowa City

Financial History

Multi-year comparison from IRS filings

2024 Financial Data:

  • Total revenues: $16,482,705
  • Total expenses: $17,446,662
  • Total assets: $25,192,749
  • Staff: 16 employees

Program Allocation:

  • 92% Program Spend
  • 4% Management Spend
  • 4% Fundraising Spend

Funding Model: 100% of all donations are invested directly in melanoma research and patient engagement programs. Operating and administrative expenses are covered by the founders, ensuring donor contributions go entirely to research.

Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$5M$10M$14M$19M20202021202220232024
Metric202420232022
Total Assets$25,192,749$24,538,655$27,333,346
Revenue$16,482,705$9,291,698$11,614,639
Expenses$17,446,662$10,316,517$15,668,313
Qualifying Distributions
Net Investment Income$875,240$905,624$320,977
Distributable Amount

Giving Over Time

Total grant dollars and number of grants per year

$0$3M$6M$9M$12M22 grants202027 grants202120 grants202226 grants202329 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

COLUMBIA UNIVERSITY IRVI…$1.2MH LEE MOFFITT CANCER CEN…$1.2MMEMORIAL SLOAN KETTERING…$1.1MMASSACHUSETTS GENERAL HO…$1.0MTHE REGENTS OF THE UNIVE…$1.0MDANA-FARBER CANCER INSTI…$975KICAHN SCHOOL OF MEDICINE…$900KTHE BOARD OF TRUSTEES OF…$900KTHE REGENTS OF THE UNIVE…$628KJOHNS HOPKINS UNIVERSITY$265K

Grant Size Distribution

124 grants across all recorded years

15<$50K9$50–100K40$100–250K32$250–500K18$500K–1M10$1–5M$5M+

Open Grants

7 open opportunities from Melanoma Research Alliance Foundation

Show all 7 →

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Leadership team and compensation from IRS filings

  • Marc Hurlbert - CEO
  • Stephanie Kauffman - President and COO
  • Founders: Debra and Leon Black

The founders generously underwrite 100% of MRA's operating and administrative expenses, ensuring maximum dollars are directed to research.

Compensation Overview

From 2024 IRS filing

MARC HURLBERTCHIEF EXECUTIVE OFFICER$379KSTEPHANIE KAUFFMANPRESIDENT & COO$319KJOAN LEVYCHIEF SCIENCE OFFICER$243KJANINE RAUSCHERDIR. OF DEVELOPMENT OPERAT$108KTANISHA JACKSONSCIENTIFIC PROGRAM DIRECTO$104K

From 2024 filing

NameTitleHoursCompensation
MICHAEL KLOWDENDIRECTOR0.3
DEBRA BLACKCHAIR/CO-FOUNDER10
EVAN BAYHDIRECTOR/SECRETARY0.5
LEON BLACKDIRECTOR/CO-FOUNDER0.3
LEE ALPERTDIRECTOR0.3
MARIA BELLDIRECTOR0.3
BEN BLACKDIRECTOR0.3
BARRY COHENDIRECTOR0.3
ELLEN DAVISDIRECTOR0.3
AMANDA EILIANDIRECTOR0.3
JASON FEDERICIDIRECTOR0.3
JAMIE GERTZDIRECTOR0.3
DAISY HELMANDIRECTOR0.3
SUSAN HESSDIRECTOR0.3
DENISE KELLENDIRECTOR0.3
NANCY MARKSDIRECTOR0.3
MICHAEL MILKENDIRECTOR0.3
RICHARD RESSLERDIRECTOR0.3
MARY JO ROGERSDIRECTOR0.3
JEFFREY ROWBOTTOMDIRECTOR0.3
IAN SCHUMANDIRECTOR0.3
JONATHAN SIMONSDIRECTOR0.3
JONATHAN SOKOLOFFDIRECTOR0.3
ELIZABETH STANTONDIRECTOR0.3
SUZANNE TOPALIANDIRECTOR1
ERIC WEDELDIRECTOR0.3
JOHN HUNTERTREASURER1
MARC HURLBERTCHIEF EXECUTIVE OFFICER50$378,565
STEPHANIE KAUFFMANPRESIDENT & COO50$319,388
JOAN LEVYCHIEF SCIENCE OFFICER40$243,113
TANISHA JACKSONSCIENTIFIC PROGRAM DIRECTO40$104,074
JANINE RAUSCHERDIR. OF DEVELOPMENT OPERAT40$108,300

Recent News & Activity

Recent developments and announcements

MRA has announced multiple significant research investments in recent periods, including $12.6 million and $9.3 million commitments to cutting-edge melanoma research initiatives.

Fueling Breakthroughs: The Melanoma Research Alliance Announces $9.3M Melanoma

**Research Impact:** MRA-funded researchers have been instrumental in major melanoma breakthroughs, with 17 new therapeutic treatments for melanoma earning FDA approval since the organization's inception.

Fueling Breakthroughs: The Melanoma Research Alliance Announces $9.3M Melanoma

Subject Areas

Focus areas based on grantmaking activity

Related Funders

Similar funders by location and focus area

Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.

What could you do with Melanoma Research Alliance Foundation on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities